155 related articles for article (PubMed ID: 2751475)
1. Probucol does not affect lipoprotein metabolism in macrophages of Watanabe heritable hyperlipidemic rabbits.
Nagano Y; Kita T; Yokode M; Ishii K; Kume N; Otani H; Arai H; Kawai C
Arteriosclerosis; 1989; 9(4):453-61. PubMed ID: 2751475
[TBL] [Abstract][Full Text] [Related]
2. Probucol selectively increases oxidation of atherogenic lipoproteins in cholesterol-fed mice and in Watanabe heritable hyperlipidemic rabbits.
Lauridsen ST; Mortensen A
Atherosclerosis; 1999 Jan; 142(1):169-78. PubMed ID: 9920518
[TBL] [Abstract][Full Text] [Related]
3. In vivo inhibition of foam cell development by probucol in Watanabe rabbits.
Steinberg D; Parthasarathy S; Carew TE
Am J Cardiol; 1988 Jul; 62(3):6B-12B. PubMed ID: 3394654
[TBL] [Abstract][Full Text] [Related]
4. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.
Kita T; Nagano Y; Yokode M; Ishii K; Kume N; Ooshima A; Yoshida H; Kawai C
Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5928-31. PubMed ID: 3475709
[TBL] [Abstract][Full Text] [Related]
5. Prevention of atherosclerotic progression in Watanabe rabbits by probucol.
Kita T; Nagano Y; Yokode M; Ishii K; Kume N; Narumiya S; Kawai C
Am J Cardiol; 1988 Jul; 62(3):13B-19B. PubMed ID: 3394648
[TBL] [Abstract][Full Text] [Related]
6. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.
Carew TE; Schwenke DC; Steinberg D
Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7725-9. PubMed ID: 3478721
[TBL] [Abstract][Full Text] [Related]
7. Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
Kleinveld HA; Demacker PN; Stalenhoef AF
Arterioscler Thromb; 1994 Aug; 14(8):1386-91. PubMed ID: 8049202
[TBL] [Abstract][Full Text] [Related]
8. Probucol treatment affects the cellular composition but not anti-oxidized low density lipoprotein immunoreactivity of plaques from Watanabe heritable hyperlipidemic rabbits.
O'Brien K; Nagano Y; Gown A; Kita T; Chait A
Arterioscler Thromb; 1991; 11(3):751-9. PubMed ID: 2029510
[TBL] [Abstract][Full Text] [Related]
9. A novel mechanism by which probucol lowers low density lipoprotein levels demonstrated in the LDL receptor-deficient rabbit.
Naruszewicz M; Carew TE; Pittman RC; Witztum JL; Steinberg D
J Lipid Res; 1984 Nov; 25(11):1206-13. PubMed ID: 6520542
[TBL] [Abstract][Full Text] [Related]
10. Role of biologically modified low-density lipoprotein in atherosclerosis.
Carew TE
Am J Cardiol; 1989 Oct; 64(13):18G-22G. PubMed ID: 2679026
[TBL] [Abstract][Full Text] [Related]
11. Probucol treatment attenuates the aortic atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
Oshima R; Ikeda T; Watanabe K; Itakura H; Sugiyama N
Atherosclerosis; 1998 Mar; 137(1):13-22. PubMed ID: 9568732
[TBL] [Abstract][Full Text] [Related]
12. Beta-very low density lipoprotein uptake in cultured fibroblasts and smooth muscle cells from Watanabe heritable hyperlipidemic rabbits.
Wernette-Hammond ME; Garcia Z; Arnold KS; Innerarity TL
Arteriosclerosis; 1989; 9(4):501-10. PubMed ID: 2546526
[TBL] [Abstract][Full Text] [Related]
13. Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits.
Witting P; Pettersson K; Ostlund-Lindqvist AM; Westerlund C; Wâgberg M; Stocker R
J Clin Invest; 1999 Jul; 104(2):213-20. PubMed ID: 10411551
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of cholesteryl ester synthesis in mouse peritoneal macrophages by cholesterol-rich very low density lipoproteins from the Watanabe heritable hyperlipidemic rabbit, an animal model of familial hypercholesterolemia.
Kita T; Yokode M; Watanabe Y; Narumiya S; Kawai C
J Clin Invest; 1986 May; 77(5):1460-5. PubMed ID: 3700648
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of alpha-tocopherol, ubiquinone-10 and probucol at therapeutic doses on atherosclerosis in WHHL rabbits.
Bräsen JH; Koenig K; Bach H; Kontush A; Heinle H; Witting PK; Ylä-Herttuala S; Stocker R; Beisiegel U
Atherosclerosis; 2002 Aug; 163(2):249-59. PubMed ID: 12052471
[TBL] [Abstract][Full Text] [Related]
16. Probucol and atherosclerosis in the Watanabe heritable hyperlipidemic rabbit--long-term antiatherogenic effect and effects on established plaques.
Nagano Y; Nakamura T; Matsuzawa Y; Cho M; Ueda Y; Kita T
Atherosclerosis; 1992 Feb; 92(2-3):131-40. PubMed ID: 1632845
[TBL] [Abstract][Full Text] [Related]
17. Effect of probucol on macrophages, leading to regression of xanthomas and atheromatous vascular lesions.
Yamamoto A; Hara H; Takaichi S; Wakasugi J; Tomikawa M
Am J Cardiol; 1988 Jul; 62(3):31B-36B. PubMed ID: 3394651
[TBL] [Abstract][Full Text] [Related]
18. Uptake of acetylated LDL by peritoneal macrophages obtained from normal and Watanabe heritable hyperlipidemic rabbits, an animal model for familial hypercholesterolemia.
Ishii K; Kita T; Kume N; Nagano Y; Kawai C
Biochim Biophys Acta; 1988 Oct; 962(3):387-9. PubMed ID: 3167090
[TBL] [Abstract][Full Text] [Related]
19. The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidaemic rabbits.
Daugherty A; Zweifel BS; Schonfeld G
Br J Pharmacol; 1991 May; 103(1):1013-8. PubMed ID: 1878742
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant activity of probucol and its analogues in hypercholesterolemic Watanabe rabbits.
Mao SJ; Yates MT; Rechtin AE; Jackson RL; Van Sickle WA
J Med Chem; 1991 Jan; 34(1):298-302. PubMed ID: 1992130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
